A humanized IgG1 monoclonal antibody directed against human mesothelin with potential antineoplastic activity. Anti-mesothelin monoclonal antibody MORAb-009 binds to mesothelin, triggering an antibody dependent cellular cytotoxicity (ADCC)-mediated host immune response against mesothelin-expressing tumor cells, which may result in tumor cell lysis. Mesothelin, a 40kDa cell surface glycoprotein, is overexpressed in several human tumors, including mesothelioma and ovarian and pancreatic adenocarcinomas.
Leave a Comment
You must be logged in to post a comment.